Recovery & Performance

BPC-157 & TB-500: The Science Behind Peptide Recovery

By the ASRX Editorial Team  ·  9 min read  ·  April 2026

Two peptides dominate the conversation in athletic recovery and injury healing: BPC-157 and TB-500. Both have been studied extensively in preclinical research, and both are used clinically under physician supervision for tissue repair and recovery acceleration. Here's a clear-eyed look at what the science supports.

BPC-157: Body Protection Compound

BPC-157 is a pentadecapeptide — a 15-amino-acid chain — derived from a protein found naturally in gastric juice. It was first identified for its gastroprotective effects, but research has since expanded its applications dramatically.

Mechanisms of Action

BPC-157 works through several overlapping pathways:

Clinical context: BPC-157 is available as a compounded medication. It is not FDA-approved for human use, but is legally prescribable under 503A compounding pharmacy regulations when ordered by a licensed provider.

TB-500: Thymosin Beta-4

TB-500 is a synthetic version of Thymosin Beta-4, a protein naturally produced in high concentrations at injury sites. It's one of the most abundant peptides in human platelets and plays a critical role in wound repair and cellular regeneration.

Mechanisms of Action

BPC-157 vs TB-500: How They Compare

BPC-157

  • Stronger for gut healing
  • Tendon & ligament focus
  • Neuroprotective properties
  • Rapid local effects
  • Typically injected near injury site

TB-500

  • Systemic anti-inflammatory
  • Muscle fiber repair
  • Cardiac & vascular support
  • Works well for diffuse injuries
  • Subcutaneous or IM injection

The Blend: BPC-157 + TB-500

Many providers now prescribe a blended formulation combining both peptides. The rationale: BPC-157's local, targeted repair mechanisms complement TB-500's systemic, anti-inflammatory profile. Athletes with complex or chronic injuries often respond better to the combined approach than either peptide alone.

Who Uses Recovery Peptides?

Build Your Recovery Protocol

Take the ASRX assessment and get matched with a physician-reviewed recovery protocol — including BPC-157, TB-500, or the combined blend.

Begin Your Assessment →
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. BPC-157 and TB-500 are compounded medications not approved by the FDA for human use. They should only be used under the supervision of a licensed healthcare provider. ASRX is a telehealth coordination platform — all clinical decisions are made by independent, licensed providers.